Other Consortium Members

Patrick Bossuyt
Professor of Clinical Epidemiology, Academic Medical Center, University of Amsterdam
Patrick leads a research group that focuses on the development of methods for evaluating medical tests and biomarkers, and applies these methods in clinical trials. He also chairs the scientific advisory board of the Dutch Healthcare Institute.
Nancy Cartwright
Professor of Philosophy, University of Durham and University of California, San Diego.
Nancy is interested in philosophy and history of science (especially physics and economics), causal inference and objectivity and evidence, especially evidence-based policy.
Daniel Commenges
Research Director Emeritus at INSERM
Founder of the Biostatistics Team of Bordeaux. Currently affiliated to the "Bordeaux Population Health Research Center."
Olaf Dammann
Research Professor of Public Health and Community Medicine, Tufts University School of Medicine.
Olaf is interested in developmental disability epidemiology, perinatal epidemiology, and the theory of risk and causation.
Andy Fugard
Social scientist and lecturer, UCL Research Department of Clinical, Educational and Health Psychology
Andy is interested in using practice-based evidence to learn whether and how psychosocial interventions help.
Juanita Heymans
Medical Advisor
Juanita after studying medicine, specialised and worked as a general practitioner. Currently working at the National Health Care Institute, Amsterdam, as a medical advisor specialised in EBM assessments evaluations.
Eileen Munro
Professor of Social Policy, London School of Economics.
Eileen is interested in risk assessment and management in child protection and mental health work.
Beth Shaw
Chair, GIN AID Knowledge Working Group, NICE
Beth chairs the GIN AID Knowledge Working Group, National Institute for Health and Care Excellence (NICE), UK.
Paolo Vineis
Chair in Environmental Epidemiology, Imperial College, London
Paolo focuses on examining biomarkers of disease risk, complex exposures and intermediate biomarkers from omic platforms in large epidemiological studies as well as studying the effects of climate change on non-communicable diseases.